GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genincode GENI.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.60p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

£3.1m

FY2019FY2025

Net income

−£5.7m

FY2019FY2025

Free cash flow

−£4.1m

FY2019FY2025

Shareholders' equity

£124,000

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue£3.1m£2.7m£2.2m£1.4m£1.2m£960,801£1.9m
Gross profit£1.5m£1.4m£1.0m£632,000£593,000£523,016£1.0m
Research and development—£145,000£334,000£72,000£1,000——
Operating income−£5.9m−£5.1m−£7.2m−£5.9m−£3.5m−£1.1m−£497,420
Net income−£5.7m−£4.4m−£7.0m−£5.6m−£4.1m−£1.2m−£403,725
Diluted earnings per share-0.02-0.03-0.07-0.06-0.04-0.10-6.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets£2.4m£2.7m£4.2m£11.8m£15.2m£2.4m£489,089
Cash and short-term investments£895,000£1.2m£2.5m£9.7m£14.6m£2.0m£85,149
Total liabilities£2.3m£1.5m£2.9m£3.9m£1.5m£563,495£929,098
Debt£146,000£234,000£299,000£354,000——£330,613
Shareholders' equity£124,000£1.1m£1.3m£7.9m£13.7m£1.9m−£440,009
Shares outstanding286m177m96m96m96m11m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−£4.1m−£5.2m−£7.5m−£3.8m−£3.0m−£1.0m−£190,703
Capital spending−£44,000−£49,000−£38,000−£849,000−£145,000−£68,273−£123,674
Free cash flow−£4.1m−£5.2m−£7.5m−£4.6m−£3.2m−£1.1m−£314,377

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue£1.1m£1.5m£1.6m£1.3m£1.4m£694,500£1.2m£605,000
Gross profit£471,000£851,000£849,000£521,000£730,000£365,000£555,000£277,500
Operating income−£2.5m−£3.4m−£3.0m−£2.7m−£2.5m−£1.2m−£3.6m−£1.8m
Net income−£2.5m−£2.7m−£3.0m−£2.0m−£2.4m−£1.2m−£3.5m−£1.8m
Diluted earnings per share-0.00-0.01-0.01-0.01-0.01-0.01-0.04-0.02
Cash from operations−£3.0m—−£3.0m−£1.0m−£3.0m−£1.0m−£2.0m−£1.0m
Total assets£3.5m£2.4m£4.2m£2.7m£4.7m£4.7m£4.2m£4.2m
Cash and short-term investments£2.1m£895,000£2.5m£1.2m£3.0m£2.9m£2.5m£2.5m
Debt£98,000£95,000—£87,000£81,000£81,000£78,000£78,000
Shareholders' equity£2.1m£124,000£2.7m£1.1m£2.8m£2.8m£1.3m£1.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue29.1%26.2%—
Operating income-0.0%41.2%—
Net income0.9%37.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin51.3%49.3%49.9%—
Operating margin-190.9%-257.0%-249.6%—
Net margin-175.5%-242.5%-244.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-0.8-0.6-0.3-0.5-2.8
Price to sales1.40.90.91.910.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.